Literature DB >> 34006920

A PROSS-designed extensively mutated estrogen receptor α variant displays enhanced thermal stability while retaining native allosteric regulation and structure.

Mark Kriegel1, Hanna J Wiederanders1, Sewar Alkhashrom2, Jutta Eichler2, Yves A Muller3.   

Abstract

Protein stability limitations often hamper the exploration of proteins as drug targets. Here, we show that the application of PROSS server algorithms to the ligand-binding domain of human estrogen receptor alpha (hERα) enabled the development of variant ERPRS* that comprises 24 amino acid substitutions and exhibits multiple improved characteristics. The protein displays enhanced production rates in E. coli, crystallizes readily and its thermal stability is increased significantly by 23 °C. hERα is a nuclear receptor (NR) family member. In NRs, protein function is allosterically regulated by its interplay with small molecule effectors and the interaction with coregulatory proteins. The in-depth characterization of ERPRS* shows that these cooperative effects are fully preserved despite that 10% of all residues were substituted. Crystal structures reveal several salient features, i.e. the introduction of a tyrosine corner in a helix-loop-helix segment and the formation of a novel surface salt bridge network possibly explaining the enhanced thermal stability. ERPRS* shows that prior successes in computational approaches for stabilizing proteins can be extended to proteins with complex allosteric regulatory behaviors as present in NRs. Since NRs including hERα are implicated in multiple diseases, our ERPRS* variant shows significant promise for facilitating the development of novel hERα modulators.

Entities:  

Year:  2021        PMID: 34006920     DOI: 10.1038/s41598-021-89785-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  46 in total

Review 1.  Origins and evolutionary diversification of the nuclear receptor superfamily.

Authors:  G I Owen; A Zelent
Journal:  Cell Mol Life Sci       Date:  2000-05       Impact factor: 9.261

Review 2.  Mechanism of the nuclear receptor molecular switch.

Authors:  Laszlo Nagy; John W R Schwabe
Journal:  Trends Biochem Sci       Date:  2004-06       Impact factor: 13.807

3.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

Review 4.  The evolution of progesterone receptor ligands.

Authors:  Kevin P Madauss; Eugene L Stewart; Shawn P Williams
Journal:  Med Res Rev       Date:  2007-05       Impact factor: 12.944

5.  How many nuclear hormone receptors are there in the human genome?

Authors:  M Robinson-Rechavi; A S Carpentier; M Duffraisse; V Laudet
Journal:  Trends Genet       Date:  2001-10       Impact factor: 11.639

6.  Coupling of receptor conformation and ligand orientation determine graded activity.

Authors:  John B Bruning; Alexander A Parent; German Gil; Min Zhao; Jason Nowak; Margaret C Pace; Carolyn L Smith; Pavel V Afonine; Paul D Adams; John A Katzenellenbogen; Kendall W Nettles
Journal:  Nat Chem Biol       Date:  2010-10-10       Impact factor: 15.040

Review 7.  Estrogen receptors and human disease.

Authors:  Bonnie J Deroo; Kenneth S Korach
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

8.  NRfamPred: a proteome-scale two level method for prediction of nuclear receptor proteins and their sub-families.

Authors:  Ravindra Kumar; Bandana Kumari; Abhishikha Srivastava; Manish Kumar
Journal:  Sci Rep       Date:  2014-10-29       Impact factor: 4.379

9.  Molecular tuning of farnesoid X receptor partial agonism.

Authors:  Daniel Merk; Sridhar Sreeramulu; Denis Kudlinzki; Krishna Saxena; Verena Linhard; Santosh L Gande; Fabian Hiller; Christina Lamers; Ewa Nilsson; Anna Aagaard; Lisa Wissler; Niek Dekker; Krister Bamberg; Manfred Schubert-Zsilavecz; Harald Schwalbe
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

Review 10.  A comprehensive map of molecular drug targets.

Authors:  Rita Santos; Oleg Ursu; Anna Gaulton; A Patrícia Bento; Ramesh S Donadi; Cristian G Bologa; Anneli Karlsson; Bissan Al-Lazikani; Anne Hersey; Tudor I Oprea; John P Overington
Journal:  Nat Rev Drug Discov       Date:  2016-12-02       Impact factor: 84.694

View more
  1 in total

1.  An Engineered Thermostable Laccase with Great Ability to Decolorize and Detoxify Malachite Green.

Authors:  Guotao Mao; Kai Wang; Fangyuan Wang; Hao Li; Hongsen Zhang; Hui Xie; Zhimin Wang; Fengqin Wang; Andong Song
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.